Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML

NCT03504410 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

200

Enrollment

INDUSTRY

Sponsor class

Stopped Futile

Conditions

Relapsed/Refractory Acute Myeloid Leukemia

Interventions

DRUG: CPI-613 + High Dose Cytarabine and Mitoxantrone
DRUG: High Dose Cytarabine and Mitoxantrone
DRUG: Mitoxantrone, Etoposide and Cytarabine
DRUG: Fludarabine, Cytarabine, Filgrastim

Sponsor

Cornerstone Pharmaceuticals